RE(ACT) Congress and IRDiRC Conference 2021

13/01/2021 - 15/01/2021

The joint event including the RE(ACT) Congress – International Congress of Research on Rare and Orphan Diseases (6th edition) and IRDiRC – International Rare Diseases Research Consortium – Conference (4th edition) will be held online on 13-15 January 2021.

The overall aim of the joint event is not only to bring together scientific leaders, experts, and young researchers with patients, but also to present and promote cutting- edge research on rare and orphan diseases among the general public, industry and policy makers – all with the ultimate goal of enhancing the rapid delivery of new and promising diagnostics and therapies to patients all around the world.

The RE(ACT) Congress – International Congress of Research on Rare and Orphan Diseases – was initiated in 2012 by the BLACKSWAN Foundation to create a forum for and promote scientific cooperation and research on rare and orphan diseases. IRDiRC – launched in
April 2011 at the initiative of the European Commission and the US National Institutes of Health – fosters international collaboration on rare disease research by bringing together researchers, funders and patient advocacy organizations that work collaboratively within a
multinational consortium.

Discover more on the program here.

icalUrl: - icalLink: iCal - webCalUrl: webcal:// - webCalLink: webcal - gCalUrl: - gCalLink: 0

Subscribe To Our Newsletter

to keep you up to date on our activities and initiatives

La tua iscrizione non può essere convalidata.
La tua iscrizione è avvenuta correttamente.

We use Brevo as our marketing platform. By clicking below to submit this form, you are aware and accept that the information you have provided will be transferred to Brevo for treatment in accordance with their terms of use
Utilizziamo Brevo come nostra piattaforma di marketing. Cliccando qui sotto per inviare questo modulo, sei consapevole e accetti che le informazioni che hai fornito verranno trasferite a Brevo per il trattamento conformemente alle loro condizioni d'uso

You have Successfully Subscribed!

Pin It on Pinterest

Share This